| mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
2e-05 |
| mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
3e-05 |
| mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
3e-05 |
| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
5e-05 |
| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
6e-05 |
| mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
7e-05 |
| mRNA |
chlorambucil |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
7e-05 |
| mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
8e-05 |
| mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
9e-05 |